Institutional News articles

agenda-solaci-2019

SOLACI Agenda | The events in interventional cardiology that you can’t miss in 2019

SOLACI Agenda | The events in interventional cardiology that you can’t miss in 2019

At SOLACI we are committed to the promotion and dissemination of relevant scientific activities in the field of interventional cardiology. Therefore, below, we share a list of 2019 events that may be interesting from an educational and / or professional point of view Organize your agenda now!   03/16 – 03/18 | ACC – AMERICAN

2019 SOLACI Congress | ProEducar’s Clinical Case Contest 10th Edition

The call for Clinical Cases for the 10th ProEducar Fellows Course for Interventionists in Training is now open.     Share your work with colleagues and world wide experts in the following topics! Access and Diagnostic Tools. Complex Coronary Interventions. Structural Heart Disease. Non-Coronary Intervention.   Deadline: June 15th.   Send your case    More

Ya salipo el Programa Científico Preliminar del 10° Curso de Fellows de ProEducar

2019 SOLACI Congress | Discover the Preliminary Scientific Program of Fellow Course 10th Edition

The SOLACI-SBHCI 2019 Congress approaches and, with it, the 10th edition of the ProEducar Fellows Course. As every year, international specialists in the field will share their knowledge in practical sessions of high scientific value that will cover a wide variety of relevant topics in the area of cardiovascular interventionism.   The particularity of this year

Lo más leído de Marzo en Solaci.org

The Most Read Articles of March in Interventional Cardiology

1- What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg The decision to be made with a treatment-free patient with systolic blood pressure over 160 mmHg or diastolic blood pressure over 100 mmHg is an easy one. All guidelines agree: treatment should be started immediately alongside lifestyle changes. Read more    2-

Logo SOLACI-SBHCI 2019

SOLACI Congress 2019 | Discover the Preliminary Scientific Program

We hereby present the preliminary scientific program for the SOLACI-SBHCI 2019 Congress that will take place from August 1st to 3rd at the Frei Caneca Convention Center in the city of São Paulo, Brazil.   We hope you will enjoy these activities and attend one of the largest interventional cardiology events in Latin America. Download

Lo más leído en Enfermedades Vasculares Periféricas

The Most Relevant Articles of 2018 in Peripheral Vascular Disease

1- What’s New in the European Guidelines on Peripheral Arterial Disease Since the last version of the European guidelines on the diagnosis and treatment of peripheral arterial disease in 2011, there have been many trials and registries that warrant guideline adjustments in many aspects. The first novelty is the teamwork that gave way to these

Los artículos más importantes de 2018 en farmacología / cardiología clínica - 2° parte

The Most Relevant Articles of 2018 in Pharmacology and Clinical Cardiology – Part 2

1- What Antiplatelet Therapy Should We Use in Patients with Stroke/TIA? Interesting Results for the POINT Trial The New England Journal of Medicine (NEJM) recently published an article about the POINT trial (simultaneously presented at the European Stroke Organisation Conference), a long-awaited randomized clinical trial to assess the efficacy and safety of dual antiplatelet therapy

The Most Relevant Articles of 2018 in Pharmacology and Clinical Cardiology

1- New High Blood Pressure Guidelines The wait is finally over: the high blood pressure guidelines that have been in the works for the past 3 years saw the light of day at the American Heart Association (AHA) 2017 Scientific Sessions. Read more    2- New European Hypertension Guidelines Contrast with American Recommendations The European

Los Mejores Artículos de 2018 en Cardiopatía Estructural

The Most Important Articles of 2018 in Structural Heart Diseases

1- ESC 2018 | MITRA FR: Testing MitraClip for Secondary Mitral Regurgitation In secondary mitral regurgitation, mitral-valve leaflets and chordae are structurally normal and mitral regurgitation results from alterations in left ventricular geometry and function. Read more    2- TCT 2018 | COAPT: MitraClip in Patients with Secondary Mitral Regurgitation The prognosis of patients with

Top